Manulife (Manufacturers Life Insurance)
IBIO icon

Manulife (Manufacturers Life Insurance)’s iBio IBIO Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-136
Closed -$29.2K – 3065
2022
Q1 		$29.2K Sell
136
-97
-42% -$20.3K ﹤0.01% 3050
2021
Q4 		$64 Sell
233
-60
-20% -$22.9K ﹤0.01% 3082
2021
Q3 		$155K Buy
293
+31
+12% +$19.3K ﹤0.01% 3057
2021
Q2 		$197K Buy
262
+10
+4% +$7.29K ﹤0.01% 3112
2021
Q1 		$194K Buy
252
+11
+5% +$9.58K ﹤0.01% 2901
2020
Q4 		$126K Buy
241
+177
+277% +$144K ﹤0.01% 2908
2020
Q3 		$65K Buy
+64
New +$92.8K ﹤0.01% 2876

Other funds holding IBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s IBIO Position: Q2 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of iBio (IBIO) in Q2 2022, closing a stake of 136 shares — an estimated $29.2K sold.

Manulife (Manufacturers Life Insurance) first reported a position in IBIO in Q3 2020 and held it in 7 quarters. The position peaked at $197K in Q2 2021. 53 funds tracked by Wall St. Rank hold IBIO as of Q2 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining iBio position as of Q2 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 136 iBio shares in Q2 2022, an estimated $29.2K.
  • Manulife (Manufacturers Life Insurance) first reported a position in iBio in Q3 2020 and held it in 7 quarters.
  • Manulife (Manufacturers Life Insurance)'s iBio position peaked at $197K in Q2 2021.
  • 53 funds tracked by Wall St. Rank held iBio as of Q2 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2022, filed 15 Aug 2022.